Weight loss is an important factor in type 2 diabetes management and is often complicated by diabetic agents that promote weight gain (i.e., sulfonylureas, thiazolidinediones (TZDs), insulin)
Oral GLP-1 analogue: perspectives and impact on atherosclerosis in type 2 diabetic patients
Without a reliable dosage reference, you are left guessing, and guessing with a GLP-1 receptor agonist is a fast track to nausea, vomiting, and wasted medication
Yes, it prolongs fullness and reduces the urge to snack
The appearance can vary depending on the formulation, but most are clear liquids, sometimes with a slight color depending on additional ingredients or flavorings
This can contribute to better blood sugar control, especially in individuals with type 2 diabetes